Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma
Clinical trial NCT02163356 · TERMINATED
Trial details
- NCT number
- NCT02163356
- Sponsor
- South Plains Oncology Consortium
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2018-05-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.